2019 Annual Meeting | C212 - Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease

Date Thursday 05/09/19

Time 07:00 AM - 09:00 AM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Wayne Grody, MD, PhD

Topic(s) General Neurology

Learning Objectives Participants should be able to understand the principles of genomic medicine and the basics of common genomic diagnostic testing methodologies (e.g., clinical exome sequencing); effectively educate, counsel, and consent patients and their families regarding genomic diagnostic testing; understand, interpret, and communicate genomic diagnostic testing results to patients; and appreciate the ethical challenges inherent in genomic medicine and identify strategies to address them in clinical practice.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:30 AM EDT	Speaker	Introduction and Overview of Clinical Exome Sequencing in Neurology Brent L. Fogel, MD, PhD, FAAN
07:30 AM - 08:00 AM EDT	Speaker	Ethical and Legal Issues in Clinical Exome Sequencing for Neurologic Diseases Wayne Grody, MD, PhD
08:00 AM - 08:10 AM EDT	Speaker	Explanation of Whole-Exome Data and Variant Interpretation Hane Lee, PhD
08:10 AM - 08:50 AM EDT	Speaker	Illustrative Case Examples of Utility of Exome Sequencing in Patients with Undiagnosed Neurologic Disorders
08:50 AM - 09:00 AM EDT	Q&A	Questions and Answers

Faculty Disclosures
Wayne Grody, MD, PhD	Dr. Grody has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for RavGen. The institution of Dr. Grody has received research support from ArmGenia. Dr. Grody has received publishing royalties from a publication relating to health care.
Brent L. Fogel, MD, PhD, FAAN	Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromarkers. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. The institution of Dr. Fogel has received research support from US Department of Defense .
Hane Lee, PhD	Dr. Lee has nothing to disclose.

��ɫ��

��ɫ��